Skip to main content
Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
OSEL Devices Ltd

| Q4 FY26 Earnings Conference Call

BULLISH SENTIMENT

Report Source

8th Jun 26

Summary : OSEL Devices reported strong FY26 growth across diversified high-growth segments, driven by strategic expansions and improved margins.

Management Perspective positive : In financial year '26 was a strong year. We are looking forward to our JNPA SEZ hub. We believe the next phase of growth will be both large in scale and higher in quality. We are expecting both growth and EBITDA margins to get better from here, at least for next four-five years. We are very much positive about our growth.

Concall Report Analysis & Insights

Business Overview

  1. OSEL operates in LED display, hearing aids, and mobile devices.
  2. The company owns the full value chain from R&D to after-sales.
  3. Holds US FDA, ISO 13485, CDSCO MD5 certifications.
  4. Utilizes a proprietary CMS platform and SFL clinic network for recurring revenue.

Future Growth Prospects

  1. JNPA SEZ hub commercialization by April 2027 will expand exports and OEM capacity.
  2. SEZ tax benefits and US FDA registration will unlock the US hearing aid market.
  3. Expects significant growth in mobile phone sales, especially smartphones.
  4. SFL acquisition will boost retail margins for hearing aids.
  5. Targeting INR50 crores in export sales this year.

Management Insights

  1. FY26 revenue grew 56.9% to INR292.7 crores.
  2. EBITDA expanded 57.9% to INR53.3 crores, with 18.2% margin.
  3. Profit after tax grew 45.7% to INR29.2 crores.
  4. All three verticals contributed to growth; export revenues crossed INR23 crores.
  5. Cash flow statement reclassification corrected previous erroneous reporting.

Signs of Skepticism

  1. Initial cash flow statement classification was erroneous and required reclassification.
  2. Interest costs nearly doubled in H2 FY26, raising questions about steady-state costs.
  3. Specific capex numbers for the JNPA project are not yet finalized.
  4. Mobile phone segment has lower margins compared to hearing aids.
  5. Some bad debts are outstanding for over a year.

Risk Factors

  1. Forward-looking statements involve inherent risks and uncertainties.
  2. Interest costs almost doubled in H2 FY26 due to mutual fund financing.
  3. Working capital utilization needs improvement to reduce interest terms.
  4. Logistics delays and supply chain disruptions impacted H2 revenue.
  5. INR10-12 lakhs in bad debt outstanding for over a year.

Good To Know

  1. Company holds Philips brand license for mobile phones.
  2. Mobile phone manufacturing is currently outsourced to a third party.
  3. Hearing aids are considered the most profitable product due to high margins.
  4. LED business is project-based, with SaaS platform for recurring revenue.
  5. SFL clinics operate as multi-brand centers for hearing aids.
  6. New CFO and experienced team members have been hired.

Key Drivers

  1. JNPA SEZ hub commercialization.
  2. SFL acquisition boosts retail.
  3. New defense segment focus.
  4. Strong growth in all verticals.

Key Analyst Discussions

Competitive Environment

  1. Questions on mobile phone manufacturing strategy and Philips brand tie-ups.
  2. Inquiries about market share in the Indian hearing aid market.
  3. Discussions on competition in hearing aids, especially from big international brands.
  4. Questions about China plus one strategy for LED business at JNPA SEZ.

Market Trends & Consumer Behavior

  1. Questions on mobile phone market penetration and growth goals.
  2. Inquiries about the untapped Indian hearing aid market potential.
  3. Discussions on B2C penetration strategy for hearing aids via SFL acquisition.
  4. Questions about online sales strategy for mobile phones.

Financial Highlights

  1. Analysts questioned cash flow statement reclassification and interest cost increases.
  2. Queries on future capex for the JNPA project were raised.
  3. Questions about FY27/FY28 revenue growth and EBITDA margin sustainability.
  4. Inquiries about segmental margin breakup, especially for hearing aids.
  5. Questions regarding outstanding receivables and bad debts.

Product Composition

  1. Questions on mobile phone revenue contribution and future goals.
  2. Inquiries about moving to mid-range and high-end hearing aid products.
  3. Discussions on LED segment profit drivers (sales vs. advertisement platform).
  4. Questions on the impact of SFL acquisition on hearing aid revenue mix.

Strategic Considerations

  1. Detailed questions on the JNPA SEZ hub's strategic advantages and target segments.
  2. Inquiries about the SFL acquisition's role in increasing hearing aid margins.
  3. Questions on the strategy for targeting the government and defense segments.
  4. Discussions on export opportunities for mobile phones and LED products.
OSEL Devices Ltd (OSELDEVICE) Concall Report Analysis & Insights | Dhanarthi